SMARCA2 and lung adenocarcinoma: In 2174 lung adenocarcinomas, SMARCA2-negative expression (n = 205) was significantly correlated with high-grade nuclei, eosinophilic staining of the cytoplasm, solid and micropapillary histological subtypes, TTF-1-negative expression and Napsin-A-negative expression (P < 0.05).